NEW YORK (GenomeWeb) – Myriad Genetics said yesterday that it has completed its acquisition of mental health-focused pharmacogenetics firm Assurex Health.

Last month, Myriad announced that it agreed to buy Assurex for $225 million in upfront payments, plus up to $185 million in performance-based milestones. Myriad said that it entered into a $200 million credit agreement with JP Morgan Chase Bank to fund the acquisition.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.